Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050Simiao Chen, Chen Wang, Zhong Cao et al.|JAMA Oncology|2023Cited by 822
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunityYugang Guo, Li Tang, Yuqing Xie et al.|Nature Immunology|2021Cited by 422
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencingChengdi Wang, Weimin Li|Signal Transduction and Targeted Therapy|2022Cited by 218
Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancerYi Lei, Weimin Li|Oncology Reports|2018Cited by 166
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including OmicronBaoxue Quan, Shengyong Yang, Huiping Shuai et al.|Nature Microbiology|2022Cited by 101